|
2004 Conference Publication Eugenol treatment corrects vascular and neural deficits in diabetic ratsCotter, MA, Gibson, TM, Nangle, MR and Cameron, NE (2004). Eugenol treatment corrects vascular and neural deficits in diabetic rats. 64th Annual Meeting of the American-Diabetes-Association, Orlando Fl, Jun 04-08, 2004. AMER DIABETES ASSOC. |
|
2004 Conference Publication Benfotiamine treatment improves vascular endothelium and nerve function in diabetic ratsCameron, NE, Nangle, MR, Gibson, TM and Cotter, MA (2004). Benfotiamine treatment improves vascular endothelium and nerve function in diabetic rats. 64th Annual Meeting of the American-Diabetes-Association, Orlando Fl, Jun 04-08, 2004. AMER DIABETES ASSOC. |
|
2004 Journal Article An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient miceNangle, M. R., Cotter, M. A. and Cameron, N. E. (2004). An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient mice. Pflugers Archiv European Journal of Physiology, 448 (2), 139-145. doi: 10.1007/s00424-003-1232-7 |
|
2003 Journal Article An in vitro study of corpus cavernosum and aorta from mice lacking the inducible nitric oxide synthase geneNangle, Matthew R., Cotter, Mary A. and Cameron, Norman E. (2003). An in vitro study of corpus cavernosum and aorta from mice lacking the inducible nitric oxide synthase gene. Nitric Oxide: Biology and Chemistry, 9 (4), 194-200. doi: 10.1016/j.niox.2004.01.006 |
|
2003 Journal Article Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid loweringNangle, Matthew R., Cotter, Mary A. and Cameron, Norman E. (2003). Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering. Diabetes, 52 (9), 2396-2402. doi: 10.2337/diabetes.52.9.2396 |
|
2003 Journal Article Protein kinase Cβ inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic miceNangle, Matthew R., Cotter, Mary A. and Cameron, Norman E. (2003). Protein kinase Cβ inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice. European Journal of Pharmacology, 475 (1-3), 99-106. doi: 10.1016/S0014-2999(03)02113-7 |
|
2003 Journal Article Looking to the future: Diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes modelsCameron, Norman, Cotter, Mary, Inkster, Melanie and Nangle, Matthew (2003). Looking to the future: Diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models. Diabetes Research and Clinical Practice, 61 (SUPPL. 1), S35-S39. doi: 10.1016/S0168-8227(03)00123-2 |
|
2002 Conference Publication Effects of diabetes and rosuvastatin treatment on mouse corpus cavernosum nitrergic innervation and aorta and cavernosum endothelium-dependent vasodilation.Nangle, MR, Cotter, MA and Cameron, NE (2002). Effects of diabetes and rosuvastatin treatment on mouse corpus cavernosum nitrergic innervation and aorta and cavernosum endothelium-dependent vasodilation.. 38th EASD Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Budapest Hungary, Sep 01-05, 2002. SPRINGER-VERLAG. |
|
2001 Conference Publication Effects of rosuvastatin on small nerve fibre function, ganglion blood flow and endothelium-dependent relaxation in diabetic rats.Nangle, MR, Inkster, ME, Cotter, MA and Cameron, NE (2001). Effects of rosuvastatin on small nerve fibre function, ganglion blood flow and endothelium-dependent relaxation in diabetic rats.. SPRINGER-VERLAG. |
|
2001 Conference Publication Effects of rosuvastatin, a new HMG-CoA reductase inhibitor, on neurovascular function in diabetic ratsCameron, NE, Inkster, ME, Nangle, MR, Smith, GJ, McTaggart, F and Cotter, MA (2001). Effects of rosuvastatin, a new HMG-CoA reductase inhibitor, on neurovascular function in diabetic rats. AMER DIABETES ASSOC. |
